SANUWAVE Health (SNWV) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.85% |
| Dec 31, 2025 | 21.61% |
| Sep 30, 2025 | 22.57% |
| Jun 30, 2025 | 16.56% |
| Mar 31, 2025 | -15.30% |
| Dec 31, 2024 | -37.07% |
| Sep 30, 2024 | -50.42% |
| Jun 30, 2024 | 33.64% |
| Mar 31, 2024 | -16.91% |
| Dec 31, 2023 | 61.09% |
| Sep 30, 2023 | -95.72% |
| Jun 30, 2023 | -20.25% |
| Mar 31, 2023 | -17.43% |
| Dec 31, 2022 | -15.45% |
| Sep 30, 2022 | -6.00% |
| Jun 30, 2022 | 25.88% |
| Mar 31, 2022 | -59.54% |
| Dec 31, 2021 | -30.98% |
| Sep 30, 2021 | -30.12% |
| Jun 30, 2021 | -50.33% |
| Mar 31, 2021 | -23.41% |
| Dec 31, 2020 | -60.28% |
| Sep 30, 2020 | -65.21% |
| Jun 30, 2020 | -19.01% |
| Mar 31, 2020 | -20.96% |
| Dec 31, 2019 | -65.19% |
| Sep 30, 2019 | -12.98% |
| Jun 30, 2019 | -10.05% |
| Mar 31, 2019 | 3.04% |
| Dec 31, 2018 | -9.15% |
| Sep 30, 2018 | 28.57% |
| Jun 30, 2018 | -28.69% |
| Mar 31, 2018 | -1.75% |
| Dec 31, 2017 | -10.39% |
| Sep 30, 2017 | 10.07% |
| Jun 30, 2017 | 0.12% |
| Mar 31, 2017 | 23.10% |
| Dec 31, 2016 | -0.34% |
| Sep 30, 2016 | 11.26% |
| Jun 30, 2016 | 20.67% |
| Mar 31, 2016 | 4.61% |
| Dec 31, 2015 | 29.95% |
| Sep 30, 2015 | 17.35% |
| Jun 30, 2015 | 11.02% |